Roche's antiobesity drug clears hurdle; U.S. panel's marketing clearance boosts stock
Article Abstract:
Roche Holding Ltd (Basel, Switzerland) gained marketing clearance for its antiobesity drug Xenical on Apr 23, 1999, causing the company's stock to jump 4.3%. Xenical was launched in Europe in Sep 1998, but its US launch was delayed while a possible breast cancer link was investigated. Marketing is expected to begin in early May 1999. One analyst expect Xenical sales to total 2.3 billion francs by 2005. For its first few years of release, Xenical is expected to dominate the market for obesity treatments, along with BASF AG's Meridia.
Comment:
Roche Holding Ltd (Basel, Switzerland) gains marketing approval for the antiobesity drug Xenical
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
British Biotech shares fall by 16% after drug trial
Article Abstract:
Shares in British Biotech Plc fell 16% after the company's flagship anticancer drug marimastat failed expected goals in its clinical trial in treating advanced pancreatic cancer. The scientific setback rekindled questions about the company's survival and sent British Biotech shares down to 21.75 pence (35.3 cents), down 4.25 pence, in London trading. As recently as May 1997, British Biotech's stock peaked at 270.5 pence, but has steadily decreased due to disappointing results for experimental drugs and management turmoil.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
European patients fight for access to cancer drugs
Article Abstract:
This article chronicles the difficulties European patients experience in getting anticancer drugs. In several countries, the U. K. for example, government agencies refuse to pay for certain drugs or restrict the number of prescriptions that doctors may issue.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Fininvest SpA's listing expected to face hurdles. EPlanet shares fall amid cash crunch; buyer is sought. Art'e' plans to bring modern art - and itself public
- Abstracts: China's telecom forays squeeze struggling rivals. Unease about U.S. role in global recovery grows. German Economy grew by 2.3% In First Quarter
- Abstracts: Military recruiters face a tough sell in job-rich U.S. Breaking a taboo, army confronts guilt after combat. Generals, entrepreneurs start sites for soldiers
- Abstracts: EU investigates Coke on antitrust suspicion. U.K. referendum ups the ante for EU: Blair's policy reversal on constitution puts pressure on France, others
- Abstracts: Investors seek strategy answers from BAA chief. BAA's profit seen hurt by pound, rail service losses